News

Everett disposed of 11% of his direct equity holdings under a pre-arranged Rule 10b5-1 trading plan, leaving a stake valued at $1.45 million.

Its deepest fall inside a market shock is not its deepest fall, and that gap is what a holder should size for.

Investors pay particular attention to a health insurer’s second-quarter report, which reflects more medical claims data among members.

Investing.com -- Jefferies downgraded Cigna to Hold from Buy, arguing that a growing list of earnings headwinds and limited catalysts outweigh the stock's discounted valuation, while cutting its price target to $307 from $336.

The stock's current valuation looks steep, but for a patient holder, the price tag on future earnings tells a very different story.

(Updates with Claritev's response in the fourth paragraph.) The US Justice Department recently se

(Update with the Justice Department's response to a request for comment in the third paragraph.)

The Cigna Group (NYSE:CI) has been removed from several major Russell equity indices, including the Russell 1000 Growth and Russell 3000 Growth. The index changes affect Cigna’s inclusion in a suite of widely referenced benchmarks used by many institutional and passive investors. These adjustments can influence portfolio rebalancing, fund flows, and the visibility of Cigna’s stock, separate from its business operations. Cigna Group is a large health services company with a focus on medical...

Cerebras initiated, Crocs upgraded: Wall Street's top analyst calls

Most companies fail within five years—but Molson Coors, Cigna, and JPMorgan Chase have survived for more than 200. Their playbook: Pick the right business—and avoid disaster.

By Amina Niasse NEW YORK, June 2 (Reuters) - Health insurer Cigna will stop covering GLP-1 weight-loss drugs including Novo Nordisk's Wegovy and Eli Lilly's Zepbound in its employee health plan

While Cigna has lagged behind the broader healthcare sector over the past year, Wall Street analysts remain highly bullish about the stock’s prospects.

The Cigna Group (NYSE:CI) is included among the 10 Best Long-Term Dividend Stocks to Invest In According to Billionaires. On May 26, Barclays turned more cautious on The Cigna Group (NYSE:CI), downgrading the stock to Equal Weight from Overweight. It also trimmed its price target on the stock to $304 from $310.The firm said Cigna […]

With an annual dividend yield of 2.19%, The Cigna Group (NYSE:CI) is included among the 12 Best Dividend Stocks to Invest in According to Hedge Funds. The Cigna Group (NYSE:CI) is a global health company that provides insurance and related products and services. It operates through two segments: Evernorth Health Services and Cigna Healthcare. On May 20, […]

Cigna raises 2026 profit outlook after a first-quarter beat, while exiting ACA plans and reviewing EviCore strategic options.